Earnings FeedTerminal

⌘K

Home/Insiders/NUDELMAN PHILLIP M PHD

NP

SEC Insider//CIK 0001041084

NUDELMAN PHILLIP M PHD

CIK 00010410841 companySEATTLE, WA

Transactions

50

Companies

1

Filings

4

CIK

0001041084

Recent Transactions

50 trades

Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-30$1.45/sh−135,620→ 342,174 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.45/sh−1,000→ 490,694 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.45/sh−12,900→ 477,794 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.45/sh−480→ 491,694 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−13,000→ 1,231,559 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−79,100→ 1,106,459 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−33,200→ 1,197,959 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−400→ 1,231,159 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−47,600→ 1,058,859 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−13,200→ 1,045,659 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−12,400→ 1,185,559 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.58/sh−1,100→ 1,244,559 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+776,411→ 1,204,233 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+776,411→ 1,204,233 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−249,759→ 427,822 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−249,759→ 427,822 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−10,741→ 2,315,382 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−4,651→ 2,326,123 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−6,345→ 2,334,574 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−3,800→ 2,330,774 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.36/sh−6,645→ 2,340,919 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.36/sh−5,801→ 2,347,564 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.36/sh−1,500→ 2,353,365 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−517→ 2,314,865 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.36/sh−1,500→ 2,353,365 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−10,741→ 2,315,382 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−3,800→ 2,330,774 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−4,651→ 2,326,123 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.36/sh−5,801→ 2,347,564 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.36/sh−6,645→ 2,340,919 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−6,345→ 2,334,574 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-31$0.37/sh−517→ 2,314,865 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−2,100→ 2,472,765 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−2,600→ 2,438,973 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−13,700→ 2,441,573 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−17,492→ 2,455,273 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.39/sh−800→ 2,434,865 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.39/sh−3,308→ 2,435,665 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−2,100→ 2,472,765 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.39/sh−800→ 2,434,865 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−2,600→ 2,438,973 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−13,700→ 2,441,573 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.39/sh−3,308→ 2,435,665 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-09-30$0.38/sh−17,492→ 2,455,273 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-04-01+482,759→ 542,832 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2008-06-23+750→ 3,750 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2008-06-23+750→ 3,750 total
Award
CTI BIOPHARMA CORP
Common Stock
2008-06-19+9,000→ 100,726 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2008-06-19+36,000→ 36,000 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2008-06-19+36,000→ 36,000 total

Companies

1

CTI BIOPHARMA CORP
Director

Recent Filings

4

Address

501 ELLIOTT AVE W, SUITE 400

SEATTLE, WA, 98119

View on SEC.gov